These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22156921)
1. Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course. Perez-Lloret S; Rojas GM; Menoni MC; Ruiz G; Velásquez C; Rodriguez H; Rey MV; Cardinali AD; Clin Neuropharmacol; 2012; 35(1):21-4. PubMed ID: 22156921 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study. Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106 [TBL] [Abstract][Full Text] [Related]
3. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Sabatowski R; Gálvez R; Cherry DA; Jacquot F; Vincent E; Maisonobe P; Versavel M; Pain; 2004 May; 109(1-2):26-35. PubMed ID: 15082123 [TBL] [Abstract][Full Text] [Related]
4. Patient-reported outcomes in subjects with neuropathic pain receiving pregabalin: evidence from medical practice in primary care settings. Navarro A; Saldaña MT; Pérez C; Torrades S; Rejas J Pain Med; 2010 May; 11(5):719-31. PubMed ID: 20345618 [TBL] [Abstract][Full Text] [Related]
5. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Toth C Pain Med; 2010 Mar; 11(3):456-65. PubMed ID: 20113408 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China. Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113 [TBL] [Abstract][Full Text] [Related]
7. Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Tölle T; Freynhagen R; Versavel M; Trostmann U; Young JP Eur J Pain; 2008 Feb; 12(2):203-13. PubMed ID: 17631400 [TBL] [Abstract][Full Text] [Related]
8. A prospective, open-label, multicentre study of pregabalin in the treatment of neuropathic pain in Latin America. Xochilcal-Morales M; Castro EM; Guajardo-Rosas J; Obregón TN; Acevedo JC; Chucan JM; Plancarte-Sanchez R; Davila G; Wajsbrot D; Guerrero M; Vinueza R Int J Clin Pract; 2010 Aug; 64(9):1301-9. PubMed ID: 20487048 [TBL] [Abstract][Full Text] [Related]
9. Cross-sectional evaluation of patient functioning and health-related quality of life in patients with neuropathic pain under standard care conditions. Gálvez R; Marsal C; Vidal J; Ruiz M; Rejas J Eur J Pain; 2007 Apr; 11(3):244-55. PubMed ID: 16563819 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study. Baron R; Brunnmüller U; Brasser M; May M; Binder A Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109 [TBL] [Abstract][Full Text] [Related]
11. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Ahn SH; Park HW; Lee BS; Moon HW; Jang SH; Sakong J; Bae JH Spine (Phila Pa 1976); 2003 Feb; 28(4):341-6; discussion 346-7. PubMed ID: 12590206 [TBL] [Abstract][Full Text] [Related]
12. Relationship between pain relief and improvements in patient function/quality of life in patients with painful diabetic peripheral neuropathy or postherpetic neuralgia treated with pregabalin. Vinik A; Emir B; Cheung R; Whalen E Clin Ther; 2013 May; 35(5):612-23. PubMed ID: 23541708 [TBL] [Abstract][Full Text] [Related]
13. Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Pérez C; Navarro A; Saldaña MT; Masramón X; Rejas J Clin Ther; 2010 Jul; 32(7):1357-70. PubMed ID: 20678683 [TBL] [Abstract][Full Text] [Related]
14. Pregabalin and transcutaneous electrical nerve stimulation for postherpetic neuralgia treatment. Barbarisi M; Pace MC; Passavanti MB; Maisto M; Mazzariello L; Pota V; Aurilio C Clin J Pain; 2010 Sep; 26(7):567-72. PubMed ID: 20639738 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study. Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293 [TBL] [Abstract][Full Text] [Related]
16. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Baron R; Mayoral V; Leijon G; Binder A; Steigerwald I; Serpell M Curr Med Res Opin; 2009 Jul; 25(7):1663-76. PubMed ID: 19485723 [TBL] [Abstract][Full Text] [Related]
17. Long-term maintenance of response across multiple fibromyalgia symptom domains in a randomized withdrawal study of pregabalin. Pauer L; Atkinson G; Murphy TK; Petersel D; Zeiher B Clin J Pain; 2012 Sep; 28(7):609-14. PubMed ID: 22688598 [TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin. Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354 [TBL] [Abstract][Full Text] [Related]
19. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Crofford LJ; Rowbotham MC; Mease PJ; Russell IJ; Dworkin RH; Corbin AE; Young JP; LaMoreaux LK; Martin SA; Sharma U; Arthritis Rheum; 2005 Apr; 52(4):1264-73. PubMed ID: 15818684 [TBL] [Abstract][Full Text] [Related]
20. An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia. Pauer L; Winkelmann A; Arsenault P; Jespersen A; Whelan L; Atkinson G; Leon T; Zeiher B; J Rheumatol; 2011 Dec; 38(12):2643-52. PubMed ID: 21965636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]